Somerville, MA, United States of America

Chris Brassard



 

Average Co-Inventor Count = 10.5

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Inventor Chris Brassard

Introduction

Chris Brassard, an accomplished inventor based in Somerville, MA, has made significant strides in the field of pharmaceutical innovations. With a total of eight patents to his name, Brassard focuses on creating compounds that can address critical health issues, particularly in the treatment of cell proliferative disorders such as cancer.

Latest Patents

Among his most recent patents are the "Substituted imidazopyridinyl-aminopyridine compounds." This invention pertains to methods of synthesizing these compounds, which are also integrated into pharmaceutical compositions aimed at treating cancer. Similarly, he has developed "Substituted imidazopyridinyl compounds," which follow a parallel framework, focusing on both their synthesis and therapeutic applications in medicinal treatments.

Career Highlights

Chris Brassard is currently affiliated with Arqule, Inc., where he applies his innovative expertise in drug development. His work is critical to advancing medical treatments and understanding how specific compounds can be utilized in real-world applications.

Collaborations

Throughout his career, Brassard has collaborated with notable peers, including Mark Anthony Ashwell and Anton Filikov. These partnerships have enabled further research and development in the field, fostering a collaborative environment that enhances the innovation landscape.

Conclusion

Chris Brassard is a noteworthy figure in pharmaceutical innovation, with his contributions to the development of cancer treatments through novel compounds. His dedication to synthesizing new therapeutic solutions reflects his commitment to improving health outcomes and advancing medical science. The impact of his work will likely continue to resonate within the industry as more patients benefit from these groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…